Developed as part of a broader collaboration between the two firms, the tool uses generative AI to let providers ask questions and describe conditions in plain language.

Stakeholders suggested that while the FDA rule is dead, updates to LDT regulation are coming, nonetheless, and the industry ...

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus ...

The laboratory medicine organization is focused on the benefits of using data science within laboratories to more effectively care for patients and track utilization.

Cemhan Biricik, CEO of Fast Lab Technologies, and Martin Perlin, its medical director, are alleged to have billed public and private payors for testing that was never done.

China's volume-based procurement policy and US tariffs have forced companies with large businesses in China to reset their ...

The development marks a shift up the value chain for labs and could prove a meaningful revenue stream for providers able to ...

Some experts believe a technological tipping point is imminent, if not already here, but adoption of point-of-care MDx has ...

Through clinical trials, partnerships, and economic studies, a crop of test developers is trying to prove the value of their ...

The company reported 5 percent growth in Europe and 3 percent growth in North America, while its revenues in the rest of the world dipped 2 percent.

The firm expects to see growth in its life science business, in particular after it showed positive signs during the second quarter.

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus on existing disease areas.